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Abstract
Objective and design To explore the role of mammalian
target of rapamycin 2 (mTORC2) in the activation of
inflammatory and oxidative responses in rodent models of
acute injury and metabolic stress.
Material The impact of nephrilin, an inhibitor of
mTORC2 complex, was assessed in three CD-1 mouse
models of acute xenobiotic stress and in a hypertensive
Dahl rat model of metabolic stress.
Methods Animals received daily subcutaneous bolus
injections of saline or 4 mg/kg nephrilin. Tissues were
assayed by ELISA, gene arrays and immunohistochemical
staining.
Results Nephrilin significantly inhibited elevations in
plasma tumor necrosis factor-alpha, kidney substance P,
and CX3CR1, and urinary lipocalin-2 [urinary neutrophil
gelatinase-associated lipocalin (uNGAL)] in models of
acute xenobiotic stress. UCHL1 gene expression levels
dropped and plasma HMGB1 levels rose in the rhabdo-
myolysis model. Both effects were reversed by nephrilin.
The inhibitor also blocked diet-induced elevations of
uNGAL and albumin-creatinine ratio (UACR) as well as
kidney tissue phosphorylation of PKC-beta-2-T641 and
p66shc-S36, and reduced dark ring-like staining of nuclei
by anti-phos-p66shc-S36 antibody in frozen sections of
diseased kidneys from hypertensive Dahl rats fed an 8 %
NaCl diet for 4 weeks.
Conclusions Taken together, our results suggest a role for
mTORC2 in the inflammatory-oxidative responses to
stress.
Keywords Nephrilin  mTORC2  Substance P 
NGAL  UCHL1
Introduction
Under stress, mammals unleash inflammatory cytokines
and cellular reactive oxygen species via linked mechanisms
that are only partially understood [1, 2]. In humans, sys-
temic inflammatory responses to traumatic stress can lead
to sepsis and high mortality in the intensive care unit,
especially when marked by kidney injury [3]. Urinary
neutrophil gelatinase-associated lipocalin (uNGAL) has
been used as a reliable early marker of such injury in
critical care settings [4, 5]. The inflammatory and oxidative
processes underlying the pathology of these life-threaten-
ing conditions are not well characterized, but are hallmarks
of a variety of insults including ischemic injury, rhabdo-
myolysis, burns, and xenobiotic and physical trauma [6].
A parallel phenomenon of underlying oxidative damage
triggered by stress has also been suggested for disease
conditions ranging from diabetes to cancer [7, 8]. We are
interested in investigating conserved mechanisms that may
link stress to dysfunctional inflammation and oxidative
circuitry.
Rictor-containing mammalian target of rapamycin 2
(mTORC2) is an evolutionarily conserved regulatory
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complex. Unlike its well-known counterpart, Raptor-con-
taining mTORC1, mTORC2 is rapamycin-insensitive and
believed to play a role in cell shape, cell motility, and
responses to stress [9, 10] by phosphorylating AGC family
kinases such as AKT, PKC, and SGK [11, 12]. In diabetic
models of kidney disease, nephrilin, a peptide inhibitor of
mTORC2, partially protects against kidney dysfunction. In
these models, it has been suggested that its action involves
the disruption of a stress-induced Rictor::IRS complex
[13].
In this study, the inflammatory process triggered by
stress was assessed using a series of inflammatory markers
of macrophage infiltration, neurogenic inflammation, and
mitochondrial oxidative metabolism. The involvement of
substance P-positive C-fibers in the initiation of inflam-
matory processes in response to traumatic stress has been
previously suggested. Ubiquitin carboxy-terminal hydro-
lase L1 (UCHL1, PGP9.5), abundantly expressed in
neurons, is a known co-regulator of anti-inflammatory p53
activity and NF-kappa-B activation [18–23]. Macrophage-
mediated tissue inflammation [24] can be accompanied by
disruptions in mitochondrial oxidative metabolism [25] and
cell morphology, particularly the adoption of mesenchymal
characteristics by epithelial cells [26]. Mitochondrial gen-
eration of reactive oxygen species is mediated by the
adaptor protein p66shc [27, 28], which is itself activated by
phosphorylation at serine 36 by PKC-beta-II [29].
Post-traumatic elevation in plasma inflammatory mark-
ers, such as high-mobility group protein B1 (HMGB1) and
tumor necrosis factor-alpha (TNF-alpha), occurs in parallel
with tissue infiltration by activated M1 macrophages and
other leukocytes [14, 15], but in burn models of bacterial
sepsis, for example, the exaggerated inflammatory response
is not always effective at combating infection [16, 17].
In this work, we study the effect of inhibiting Rictor
binding to its cofactor Protor [13, 30] on inflammatory
processes triggered by xenobiotic stress in three previously
described CD1 mouse models of acute xenobiotic injury
[31, 32]. We also explore longer-term effects on oxidative
metabolism using a salt-sensitive hypertensive Dahl rat
model [33]. The major aim of this study was to define the
role of mTORC2 as a transducer of cellular stress in tissue.
Materials and methods
Reagents
Nephrilin peptide was custom synthesized by Genemed
Synthesis (San Antonio, TX, USA). Phosphosafe cell
extract reagent was from Novagen (Madison, WI, USA)
and BCA Protein Kit from Pierce (Rockford, IL, USA).
Antibodies for ELISAs were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA) except for phospho-
p66shc-S36, phospho-PKC-alpha-T638, and phospho-
beta2-T641 (Abcam, Cambridge, MA, USA). Sandwich
ELISA kits for substance P, IL-6, TNF-alpha, and NGAL
(lipocalin-2) were purchased from R&D Systems (Minne-
apolis, MN, USA). HMGB1 sandwich ELISA kit was
obtained from USCN Life Science (Wuhan, China). Urine
albumin and creatinine were measured using the Albuwell
M Kit and Creatinine Companion Kit from Exocell (Phil-
adelphia, PA, USA). CelLytic M cell lysis reagent,
NXTRACT cell fractionation kit, LPS, glycerol, genta-
mycin, and cisplatin were obtained from Sigma (St. Louis,
MO, USA). Quantisure First Strand cDNA Synthesis Kit
(Accugen Biosciences, Rockville, MD, USA) was used for
quantitative PCR (qPCR) studies.
Animal studies
All experiments were approved to be conducted as outlined
here by the appropriate institutional IACUUC animal ethics
committee and carried out in accordance with established
Guiding Principles for Animal Research. Male Dahl/ss rats,
6–7 weeks old (Charles River), were fed AIN76A w/0.3 %
Na chow upon arrival at the facility, then either switched to
AIN76A w/8 % Na (high-salt diet group) or maintained on
original diet (low-salt diet group) starting on day 1. Dahl
rats on high-salt diet were either left untreated or injected
daily with either saline or 4 mg/kg nephrilin by subcuta-
neous bolus (injection volume 0.4 ml/rat) for 4 weeks. Rats
were placed in metabolic cages following the final dose for
a 12-h acclimation time, then a 12-h urine collection time.
Acute kidney injury (AKI) models using intramuscular
50 % glycerol to induce rhabdomyolysis, intraperitoneal
gentamycin (80 mg/kg), or intraperitoneal cisplatin insults
were carried out essentially as previously described
[31, 32], except that the dosing of gentamycin and cisplatin
were done as follows: gentamycin 80 mg/kg injected twice
daily (days 4 through 6), cisplatin 2.7 mg/kg daily for
5 days (days 1–5) to more closely parallel clinical practice.
Seven-week-old CD-1 mice (*30 g body weight each)
were obtained from Charles River Laboratories. Mice were
placed in metabolic cages (5 mice per cage) for a 12-h
acclimation time preceding a 12-h urine collection before
sacrifice. All mice except for the sham group received daily
subcutaneous injection of either saline or 4 mg/kg nephri-
lin, as previously described [13]. The injection volume was
0.1 ml/mouse. LPS was administered at 2 mg/kg by sub-
cutaneous injection 18 h after the last dose of glycerol,
gentamycin, or cisplatin. Blood was collected by retro-
orbital bleed under isoflurane anesthesia prior to LPS
administration. Animals were sacrificed 2 h later. In all
Dahl rat and CD1 mouse experiments, blood was addi-
tionally collected at sacrifice by terminal cardiac puncture
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under CO2 anesthesia and processed for plasma with
K-EDTA preservation at -80 C. Left kidneys were snap
frozen and stored at -80 C for analysis. Tissues were
extracted and assayed by ELISA as previously described
[13]. Segments of frozen organ tissue were used for
immunohistochemistry studies and for RNA extraction and
OneArrayTM gene array analysis as specified by the man-
ufacturer (Phalanx Biotech, Palo Alto, CA, USA). The
Accession numbers for UCHL1 and PER2 genes are
NM_011670.2 and NM_011066.3, respectively.
Cell extracts, fractionation, ELISAs
and immunoprecipitation
Kidney tissue cell extracts, cell fractions and ELISAs were
done as previously described [13, 34] except that the Sigma
NXTRACT kit was used for cell fractionation. For
immunoprecipitation of proteins bound to IRS2, kidney
slices from each treatment group were homogenized in
CelLytic M, diluted in PBS and immunoprecipitated in
Eppendorf tubes overnight at 8 C in 0.6 ml reaction vol-
ume containing approximately 1.5 mg total protein and
30 ug of anti-IRS2 antibody conjugated to agarose. Con-
jugates were pelleted by 30 s microfuge spin, and pellets
were washed once in ice-cold PBS before elution in 200 uL
0.1 M Glycine. After centrifugation, eluates were imme-
diately neutralized with 0.1 ml Trizma pH 7.8. The elution
step was repeated and the eluates were pooled for each
sample. All immunoprecipitation experiments were per-
formed in duplicate and eluates were assayed in triplicate.
Statistical analysis
Probability values (P values) were computed using Stu-
dent’s t test and expressed relative to saline-treated
controls, except where otherwise noted. Group size for all
treatment groups was five animals except for CD1 sham
group, which consisted of three animals.
Immunohistochemistry
Frozen sections were prepared and stained with anti-
phospho-p66shc-S36 antibody (Abcam 6E10, isotype
IgG1, stock concentration 0.1 mg/ml). A series of IHC
pilot sequences was first performed to find the correct
staining protocol for the antibody. Optimal staining was
found using a flash frozen rat kidney section fixed in an
acetone/ethanol solution for 5 min at room temperature
(RT). Prior to antibody staining, a mouse IgG block
(Biocare Medical RBM961H) was applied to the tissue for
30 min at RT. The primary antibody working concentration
was best at 0.002 mg/ml or (1:50) and incubated at 4 C for
18 h. The isotype negative control solution used was
Mouse IgG1 (Dako X0931) diluted to the same concen-
tration as the working antibody solution (0.002 mg/ml).
Following overnight incubation, the primary antibody was
conjugated with an anti-mouse labeled polymer (Biocare
Medical MM620H). Staining was developed with DAB?
(Dako K3468) for 5 min RT. Counter-staining was done
with Automation Hematoxylin for 10 min, RT.
Analysis of kidney tissue gene expression
RNA extraction, QC, gene array using Phalanx OneAr-
rayTM and collection of signal intensities were performed
under contract by Phalanx Biotech. Each RNA sample was
prepared from a pool of frozen kidney slices from the
animals in each treatment group. RNA showed 260/280 nm
ratios [1.95 and passed QC by gel electrophoresis and
chromatography, signal capture, and analysis were per-
formed as specified by the service provider (http://www.
phalanxbiotech.com/services/services.html). The same RNA
samples used for gene array experiments were used for first
strand cDNA synthesis using Quantisure Kit, after removal
of gDNA using gDNA-removing buffer (49). Reverse
transcriptase reaction contained 4 uL 59 RT buffer, 3 uL
primer mix, 1 uL enzyme mix and 12 uL RNA (1 ug). After
15 min incubation at 42 C, the reaction was terminated
(95 C for 3 min) and the cDNA was used in a qPCR
reaction using the following primer sets (primers were from
sequences conserved in rodents).
Gene Amplicon Forward primer Reverse primer













Reactions contained 12.5 uL AccuAmpTM SYBR Green
qPCR Master Mix/Low ROX (29), 1 uL (300 nM) each
primer, 2.5 uL 59-diluted cDNA, 8 uL nuclease-free water
(total reaction volume 25 uL). PCR cycling was performed
in an Agilent MX3000 real-time cycler according to
manufacturer’s instructions. Cycle conditions were set for
95 C, 10 min as an initial activation step, followed by
409 2-step cycling (95 C, 15 s followed by 55 C 1 min
with fluorescence data collected during the second step).
All experiments were done in triplicate. Delta-delta-CT
method was used to calculate fold-change in gene expres-
sion using GAPDH as the reference gene.
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Results
mTORC2 inhibition with nephrilin abrogates
the abnormal inflammatory response to xenobiotic
stress in three models of AKI
Acute xenobiotic or ischemic injury magnifies the induc-
ibility of inflammatory markers in response to LPS challenge
CD1 mouse models of AKI [31, 32]. We explored the effect
of sub-cutaneously administered nephrilin in three of these
models glycerol (rhabdomyolysis), gentamycin and cis-
platin. In all three AKI models, basal levels of plasma TNF-
alpha were below 10 pg/ml, but 2 h after LPS stimulation
(Fig. 1a) plasma TNF-alpha levels rose to significantly
higher levels in the glycerol-, gentamycin- and cisplatin-
challenged mice than in control CD-1 mice (all P \ 0.01).
Treatment with nephrilin significantly reduced plasma TNF-
alpha in xenobiotic-treated animals by at least 40 % in each
case (P \ 0.05).
HMGB1 is a canonical ligand for TLR4, which has been
shown to mediate TNF-alpha production and kidney tissue
injury in response to traumatic injury [35–37]. Plasma
HMGB1 levels in the rhabdomyolysis model were signif-
icantly elevated by LPS challenge, but not further elevated
by xenobiotic stress; however, elevated HMGB1 levels
were significantly reduced by treatment with nephrilin
(Fig. 1b).
Substance P has been implicated as an effector of neu-
rogenic inflammation in tissues and in neuropathies [18,
19]. In kidney tissue, xenobiotic stress caused a marked
elevation in substance P in all models. In each case, ne-
phrilin significantly reduced tissue levels of substance P
(Fig. 1c).
CX3CR1 is a key indicator of recruitment for M1
macrophage subsets in the context of local inflammatory
responses [15]. In the glycerol and gentamycin mouse
models, we observed significant insult-associated elevations
in CX3CR1 immunoreactivity. In the glycerol model,
treatment with nephrilin significantly lowered the level of
CX3CR1 (Fig. 1d).
Urinary neutrophil gelatinase-associated lipocalin, an early
marker of kidney injury [4, 5], is significantly elevated by
Fig. 1 Nephrilin inhibits inflammatory responses to xenobiotic
stress. Three murine models of xenobiotic insult (glycerol, gentamy-
cin, cisplatin) were used to probe inflammatory responses to stress as
described in ‘‘Materials and methods’’. Group size was five animals
per group. The time from initial insult to tissue analysis was 20 h, 3
and 6 days, respectively, for the three models. All samples shown
were collected at sacrifice. Plasma samples taken prior to LPS
challenge were confirmed to have \10 pg/ml TNF-alpha for all
animals (data not shown). Pre-challenge plasma HMGB1 in rhabd-
omyolytic (glycerol) animals was \10 ng/ml (data not shown).
a Plasma TNF-alpha levels. b Plasma HMGB1. c Substance P in
kidney tissue extracts. d CX3CR1 immunoreactivity in kidney tissue
extracts. e uNGAL-creatinine ratio in urine. No xenobiotic (white
bars), xenobiotic (black bars), xenobiotic ? nephrilin (gray bars). All
animals were challenged with LPS 2 h prior to sacrifice. The same
‘‘no xenobiotic’’ control group data (white bars) are plotted for
comparison with each of the three xenobiotic arms. *P \ 0.05,
**P \ 0.01 significance relative to insult group in each experiment.
n.d. Not determined
c
1398 D. Mascarenhas et al.
123
xenobiotic stress in all three AKI models. Daily subcuta-
neous bolus administration of nephrilin significantly
reversed this elevation in all cases (Fig. 1e).
mTORC2 regulates the activation of p66shc
in hypertensive rats
We next investigated the impact of mTORC2 inhibition in
the context of metabolic stress and oxidative metabolism.
Phosphorylation of S36 in p66shc by PKC-beta-2 has been
implicated as the key step in the generation of mitochon-
drial reactive oxygen species [29]. We have recently shown
that hyperglycemic stress elevates the phosphorylation and
intracellular localization of kidney PKC-alpha and PKC-
beta-2 in an mTORC2-dependent manner, but the antibody
used in that study could not distinguish between phos-
phorylation events at PKC-alpha-T638 and PKC-beta-2-
T641 [13]. In the present study, we used reagents specific
to each of these isoforms of phosphorylated PKC-alpha and
beta-2 to examine, whether a high-salt diet increased
phosphorylation at these sites in hypertensive Dahl rats.
Figure 2a shows that hypertensive metabolic stress signif-
icantly elevates phosphorylation of PKC-beta-2-T641, but
not PKC-alpha-T638. In Dahl rats fed a high-salt diet for
4 weeks, daily treatment with nephrilin protects against
this elevation in phosphorylation of PKC-beta-2-T641.
In these animals, both cytoplasmic and nuclear extracts of
kidney tissues also showed significantly reduced propor-
tions of p66shc phosphorylated at S36 after treatment with
nephrilin (Fig. 2a, right panel). As PKC-beta-II has been
implicated in the maturation of p66shc by S36 phosphor-
ylation [29], these observations are consistent with a
regulatory role for mTORC2 in this pathway. Maturation of
PKC alpha/beta by mTORC2 kinase has been postulated to
occur in a non-cytoplasmic compartment, possibly nuclear
[13]. In frozen sections stained with an antibody specific to
phospho-p66shc-S36, a ring-like pattern of nuclear staining
is observed (see detail in panels c, d of Fig. 3), perhaps
suggesting localization of phosphorylated p66shc within
nuclear PML-containing stress bodies [38]. Nephrilin
treatment reduced the number of dark-stained nuclei
(Fig. 3; Table 1).
In order to confirm a functional effect of nephrilin
treatment we measured uNGAL in these animals. Stress
induced a significant elevation in uNGAL and this eleva-
tion was abrogated by treatment with nephrilin (Fig. 2b).
mTORC2 regulates gene expression in response
to stress
We examined differential gene expression using gene
arrays, as described in ‘‘Materials and methods’’. Gene
Fig. 2 Nephrilin inhibits
responses to stress. Group size
was five animals per group. NS
not significant, *P \ 0.05.
a Phosphorylation of PKC and
p66shc in kidney tissue as
measured by ELISA. Results are
plotted in arbitrary units per mg
of protein relative to the control
group in each comparison
(group 1 or 3). Cyt cytoplasmic,
Nuc nuclear. b Urinary NGAL
in hypertensive rats. c Gene
expression levels relative to
GAPDH, as established by
qPCR. Left PER2 gene, right
UCHL1 gene. 1 Dahl rats, low-
salt diet; 2 Dahl rats, high salt
diet; 3 Dahl rats, high salt ?
saline; 4 Dahl rats, high salt ?
nephrilin; 5 CD1 mice, glycerol
treatment ? saline; 6 CD1 mice,
glycerol treatment ? nephrilin
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Fig. 3 Immunohistochemical
staining of frozen kidney
sections with anti-phospho-
p66shc-S36 antibody. a H&E
stain, b isotype negative control,
c, d magnification of detail in
(e, f), highlighting the circular
punctate nuclear staining,
e–g three representative animals
from saline-treated group,
h–j three representative animals
from nephrilin-treated group
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arrays were interrogated for significant changes in array
signal in triplicate. Gene tags with signal intensities below
100 (arbitrary units, common to all arrays) were ignored in
the analysis. Three pairwise comparisons were performed
(Table 2). For example, changes in kidney gene expression
attributable to salt diet in Dahl rats was done by comparing
mRNA from kidneys of animals fed low- or high-salt diets.
We used an arbitrary cutoff of 20 % (upregulated or
downregulated) with P \ 0.05 for triplicate determina-
tions. We examined changes in gene expression caused by
stress and counter-regulated by nephrilin. Using gene
arrays (Table 2) we searched for genes that were differ-
entially expressed in both rat sets. We identified two genes:
UCHL1, a protein abundantly expressed in neurons and
previously implicated in ubiquitin metabolism and PER2, a
well-known clock gene implicated in circadian function
[39, 40].
In a confirmatory step, mRNA extracted from kidneys
was queried by qPCR. Data were expressed as a ratio of
UCHL1 or PER2 gene transcript to the reference house-
keeping gene GAPDH. The results of the experiment are
shown in Fig. 2d. Both UCHL1 and PER2 were signifi-
cantly downregulated in both acute and hypertensive
models of kidney insult, but nephrilin treatment reversed
downregulation of UCHL1 in both acute (glycerol) and
hypertensive models, and reversed downregulation of
PER2 in the Dahl rat model.
Nephrilin reduces co-immunoprecipitation of Rictor
with IRS2 in AKI model
We have previously shown that an intracellular complex of
Rictor and IRS protein (IRS1 or IRS2) is rapidly formed in
human kidney cells in response to glycemic stimulus [13].
We immunoprecipitated kidney tissue extracts from Dahl
rats (high-salt diet, treated with either saline or nephrilin)
and from CD1 mice (rhabdomyolysis model) using an anti-
IRS2 antibody conjugated to agarose (see ‘‘Materials and
methods’’). The solubilized eluates from immunoprecipi-
tates were assayed by ELISA. IGF1R was used as an
internal calibration control, based on the known canonical
role of IGF1R::IRS2 complexes in cellular signaling, and
results were expressed as the ratio of Rictor to IGF1R
immunoreactivity. As shown in Table 3, nephrilin signifi-
cantly reduces the ratio of Rictor immunoprecipitated by
anti-IRS2 in the AKI model, but not in the Dahl rat model.
Discussion
The progression of events in acute injury models provides
an opportunity for investigating the biochemical sequence
that links traumatic stress with dysfunctional inflammation
and other potentially self-damaging systemic responses.
Early events associated with acute organ damage (as
measured by uNGAL in the case of AKI) appear to follow
tissue infiltration by activated monocytes and the release of
inflammatory mediators [6, 15, 31, 32]. Our data demon-
strate that nephrilin, a peptide inhibitor of mTORC2, blunts
the elevation of TNF-alpha in plasma (Fig. 1a) and of
Table 1 Percent nuclei stained with phospho-p66shc-S36 antibody
Group #
nuclei
No stain Light stain Dark stain
Saline
group
1,820 60.74 ± 4.68 10.12 ± 0.21 29.14 ± 4.47
Nephrilin
group
2,745 76.11 ± 2.29* 12.99 ± 1.03** 10.90 ± 1.98*
Dahl rats were fed a high-salt diet for 4 weeks and simultaneously
injected daily with saline or 4 mg/kg nephrilin. Frozen kidney sec-
tions were stained with anti-phospho-p66shc-S36
* P \ 0.05, ** P \ 0.01 vs. saline control
Table 2 Pairwise comparisons using gene arrays
Model Control Comparator # genetags







mRNA was extracted from frozen kidney tissue and queried as
described in ‘‘Materials and methods’’. Three separate experiments
are summarized in the table. In each experiment, the Control mRNA
was compared with the Comparator mRNA to identify differentially
expressed genes
# Genetags is the total number of genetags queried in each array





Dahl rat/high-salt diet/saline 0.950 ± 0.132
Dahl rat/high-salt diet/nephrilin 1.026 ± 0.115 0.310






0.849 ± 0.077 0.002
Kidney tissue lysates were immunoprecipitated using agarose-con-
jugated anti-IRS2 antibody, as described in ‘‘Materials and methods’’.
Eluates were assayed for Rictor and IGF1R by ELISA. Ratio is
expressed in arbitrary units. Experiments were performed twice. The
results of one representative experiment are shown in which samples
were immunoprecipitated in duplicate and each immunoprecipitate
assayed by ELISA in triplicate
a Versus saline control group
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uNGAL in urine (Fig. 1e). In kidney tissue, substance P is
released in response to trauma (all three models; Fig. 1c)
and CX3CR1 levels rise (two models; Fig. 1d), suggesting
the possibility that neurogenic inflammation may play a
role in linking stress to inflammation. Both responses are
largely abrogated by treatment with the mTORC2 inhibitor,
consistent with a regulatory role for mTORC2 (Fig. 1c, d).
The most notable effects of trauma among the markers
we measured (levels of substance P in kidney tissue and
uNGAL in urine; Fig. 1a, e) and the corresponding impact
of nephrilin on these markers are observed in the rhabdo-
myolysis model. In this model, tissue collection for analysis
is separated from the initial insult by only 20 h as compared
with the gentamycin and cisplatin models, where the time
elapsed from first insult to collection is 3 and 6 days,
respectively. It is possible, therefore, that the most dramatic
regulatory effects of mTORC2 are exerted on processes that
occur early after the initial injury. HMGB1 is a canonical
ligand for TLR4, which has been shown to mediate TNF-
alpha production and kidney tissue injury in response to
traumatic injury [35–37]. Plasma HMGB1 levels in the
rhabdomyolysis model were significantly elevated by LPS
challenge, but not further elevated by xenobiotic stress
(Fig. 1b); however, the elevated HMGB1 levels were sig-
nificantly reduced by treatment with nephrilin.
It is also possible, of course, that the three types of insult
used in the experiments (glycerol, gentamycin, cisplatin)
are just intrinsically different, and produce different
responses. Future studies focused on the time course of
trauma response will be needed to distinguish between
these possibilities.
mTORC2 may indirectly regulate inflammation in a
general sense, via its role in the maturation of AGC kina-
ses, but we also note the possibility that it may mediate a
hyper-inflammatory response to stress in animals subjected
to xenobiotic insult, at least in the three AKI models used
in this study. In that scenario, a neurogenic mechanism for
regulation is suggested by the effects of nephrilin on sub-
stance P levels (Fig. 1c) and UCHL1 gene expression
(Fig. 2d) in kidney tissue.
The potential clinical significance of these data in a
critical care context is worth noting. Over the past four
decades, mortality in critical care settings, particularly
when associated with systemic hyper-inflammation has
remained alarmingly high often exceeding 20 % [3, 41].
Recent studies have shown a strong association of such
mortality with kidney damage, and with elevated uNGAL
in particular [4, 5]. It should be noted, however, that these
are correlational observations and do not prove a causal
relationship. In some high-risk patient populations such as
those undergoing major heart surgery or those with severe
burns, mortality correlates with systemic inflammation and
kidney insult [42, 43].
Our data also demonstrate the influence of mTORC2 on
oxidative processes known to be associated with kidney
injury over an extended period following the initial insult.
In hypertensive Dahl rats, nephrilin significantly reduces
activation of PKC-beta-II by phosphorylation at T641.
PKC-beta-II has previously been shown to activate p66shc,
a key mediator of mitochondrial oxidative metabolism, by
phosphorylation of S36 [29]. In Dahl rats, nephrilin inhibits
S36 phosphorylation of kidney p66shc. The latter process
may be localized in PML-containing nuclear bodies [38],
based on the ring-like pattern of immunohistochemical
staining of frozen kidney sections with anti-phospho-
p66shc-S36 antibody.
UCHL1 gene expression, which is subject to epigenetic
silencing [44], is downregulated in rhabdomyolytic mice
and in hypertensive Dahl rats fed a high-salt diet. Nephrilin
treatment reverses this effect. The observation is intriguing
in light of recent reports linking UCHL1 to p53 function
and of both these proteins to inflammatory processes
[20–23]. The UCHL1 gene is also abundantly expressed in
neurons. UCHL1 gene silencing and the release of sub-
stance P in kidney tissue in response to stress may presage
a change of function in nociceptors and is consistent with
trauma-induced alterations in neurogenic signaling [18,
19]. In the Dahl rat model, nephrilin reverses the reduction
in PER2 gene expression, a hallmark of circadian dys-
function [40].
Given the immunohistochemical staining of frozen
kidney sections with anti-phospho-p66shc-S36, and the
ubiquitous linkage between oxidative and inflammatory
circuitry in mammalian cells, it is interesting to note that
PML-containing nuclear bodies have recently been shown
to contain p53 [45]. In future studies, it would be inter-
esting to investigate the possible role of nuclear stress
bodies in the coordination of p66shc- and NF-kappa-B-
driven processes, and the possible involvement of UCHL1
and p53 in such putative crosstalk.
We suggest that inflammatory and oxidative circuits
may be coordinately induced by stress via a temporal
sequence involving (1) reduced UCHL1 gene expression
(possibly by epigenetic silencing), (2) release of substance
P in tissue, (3) elevation of inflammatory markers, (4)
damage to kidney tubular epithelial cell function (as
measured by uNGAL), and (5) activation of PKC-beta-2,
which in turn activates p66shc, leading to mitochondrial
ROS generation [29].
Rhabdomyolytic stress, like glycemic stress [13],
appears to drive formation of an IRS2::Rictor complex in
cells, and the formation of complex is abrogated by ne-
phrilin. The role of the IRS::mTORC2 complex in medi-
ating the inflammatory and oxidative phenomena listed
above is not known. Further work is necessary to elucidate
the pathways influenced by this complex.
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Taken together, the above data suggest a protective
effect for an inhibitor of mTORC2 in both acute xenobiotic
and longer-term metabolic stress. It is tempting to specu-
late that, since many of the tissue processes explored in this
study (inflammation, oxidative damage, circadian dys-
function) appear to underlie other degenerative diseases
and aging [46–48], mTORC2 may play a broad role in
degenerative mechanisms associated with those disease
states. Even if mTORC2 inhibition does not address the
primary causes of such diseases, it may help manage the
cascade of degenerative effects set in motion by the pri-
mary insults. The generality of mTORC2 action may signal
evolutionary conservation and may represent an example
of antagonistic pleiotropy, a phenomenon that has recently
been described in connection with regulators of inflam-
matory processes such as p53 and IL-6 [49, 50].
In conclusion, we have shown that inhibition of
mTORC2 function using nephrilin inhibits markers of
inflammatory and oxidative metabolism in rodent models
featuring short-term xenobiotic or longer-term metabolic
insult. These results may suggest a conserved role for
mTORC2 complex in the biological response to stress.
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